Related Experiment Video
Updated: Sep 20, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
PROS1-MERTK Axis Drives Tumor Microenvironment Crosstalk and Progression in Papillary Thyroid Microcarcinoma
Wenqian Zhang1, Ye Zhang2, Zhu Liu1
1Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
Researchers identified the PROS1-MERTK signaling pathway as a key driver of papillary thyroid microcarcinoma (PTMC) progression. This discovery offers potential new targets for treating aggressive forms of thyroid cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Papillary thyroid carcinoma (PTC) incidence is rising, with papillary thyroid microcarcinoma (PTMC) comprising over half of cases.
- While many PTMCs are indolent, some progress, necessitating biomarkers for risk stratification.
Purpose of the Study:
- To identify biomarkers and understand mechanisms driving PTMC progression.
- To characterize the cellular ecosystem and intercellular communication in PTC progression.
Main Methods:
- Single-cell RNA sequencing and spatial transcriptomics on surgical tissue specimens.
- In vivo and in vitro experimental validation.
Main Results:
- PTMC progression involves multi-directional evolutionary patterns and altered intercellular communication.
- The PROS1-MERTK signaling axis was identified as pivotal in PTMC progression.
- NFYB and FOXP2 activate PROS1 transcription in fibroblasts, promoting progression via MERTK/WNT/TGF-β signaling.
Conclusions:
- The PROS1/MERTK axis is a critical regulator of PTMC progression within the tumor microenvironment.
- Targeting the PROS1/MERTK axis may offer therapeutic strategies for aggressive PTMC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Mitogens and the Cell Cycle

